• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-2(IL-2)、IL-7和IL-15在脐带血造血祖细胞以及γc转导的重症联合免疫缺陷X1骨髓细胞自然杀伤细胞分化中的作用。

Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency X1 bone marrow cells.

作者信息

Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, De Coene C, Selz F, Le Deist F, Fischer A

机构信息

Institut National de la Santé et de la Recherche Médicale U 429, Hôpital Necker-Enfants Malades, Paris, France.

出版信息

Blood. 1996 Nov 15;88(10):3901-9.

PMID:8916956
Abstract

Natural killer (NK) cells are characterized by their ability to mediate spontaneous cytotoxicity against susceptible tumor cells and infected cells. They differentiate from hematopoietic progenitor cells. Patients with X-linked severe combined immunodeficiency (SCID X1) carry mutations in the gamma c cytokine receptor gene that result in lack of both T and NK cells. To assess the role of interleukin-2 (IL-2), IL-7, and IL-15 cytokines, which share gamma c receptor subunit, in NK cell differentiation, we have studied NK cell differentiation from cord blood CD34 (+) cells in the presence of either stem cell factor (SCF), IL-2, and IL-7 or SCF and IL-15. The former cytokine combination efficiently induced CD34 (+) CD7 (+) cord blood cells to proliferate and mature into NK cells, while the latter was also able to induce NK cell differentiation from more immature CD34 (+) CD7 (-) cord blood cells. NK cells expressed CD56 and efficiently killed K562 target cells. These results show that IL-15 could play an important role in the maturation of NK cell from cord blood progenitors. Following retroviral-mediated gene transfer of gamma c into SCID X1 bone marrow progenitors, it was possible to reproduce a similar pattern of NK cell differentiation in two SCID-X1 patients with SCF + IL-2 + IL-7 and more efficiently in one of them with SCF + IL-15. These results strongly suggest that the gamma c chain transduces major signal(s) involved in NK cell differentiation from hematopoietic progenitor cells and that IL-15 interaction with gamma c is involved in this process at an earlier step than IL-2/IL-7 interactions of gamma c are. It also shows that gene transfer into hematopoietic progenitor cells could potentially restore NK cell differentiation in SCID X1 patients.

摘要

自然杀伤(NK)细胞的特点是能够介导针对易感肿瘤细胞和受感染细胞的自发细胞毒性。它们从造血祖细胞分化而来。患有X连锁严重联合免疫缺陷(SCID X1)的患者在γc细胞因子受体基因中携带突变,导致T细胞和NK细胞均缺乏。为了评估共享γc受体亚基的白细胞介素-2(IL-2)、IL-7和IL-15细胞因子在NK细胞分化中的作用,我们研究了在存在干细胞因子(SCF)、IL-2和IL-7或SCF和IL-15的情况下,脐血CD34(+)细胞向NK细胞的分化。前一种细胞因子组合有效地诱导CD34(+)CD7(+)脐血细胞增殖并成熟为NK细胞,而后一种组合也能够诱导更不成熟的CD34(+)CD7(-)脐血细胞分化为NK细胞。NK细胞表达CD56并能有效杀伤K562靶细胞。这些结果表明,IL-15可能在脐血祖细胞向NK细胞的成熟过程中发挥重要作用。在将γc通过逆转录病毒介导的基因转移到SCID X1骨髓祖细胞后,两名SCID-X1患者在使用SCF + IL-2 + IL-7时能够重现类似的NK细胞分化模式,其中一名患者使用SCF + IL-15时效率更高。这些结果强烈表明,γc链转导了参与造血祖细胞向NK细胞分化的主要信号,并且IL-15与γc的相互作用在这一过程中比γc与IL-2/IL-7的相互作用更早参与。这也表明将基因转移到造血祖细胞中可能潜在地恢复SCID X1患者的NK细胞分化。

相似文献

1
Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency X1 bone marrow cells.白细胞介素-2(IL-2)、IL-7和IL-15在脐带血造血祖细胞以及γc转导的重症联合免疫缺陷X1骨髓细胞自然杀伤细胞分化中的作用。
Blood. 1996 Nov 15;88(10):3901-9.
2
[Gene therapy of X-linked severe combined immunologic deficiency (SCID-X1)].[X连锁重症联合免疫缺陷(SCID-X1)的基因治疗]
Pathol Biol (Paris). 2001 Feb;49(1):57-66. doi: 10.1016/s0369-8114(00)00002-x.
3
gammac gene transfer in the presence of stem cell factor, FLT-3L, interleukin-7 (IL-7), IL-1, and IL-15 cytokines restores T-cell differentiation from gammac(-) X-linked severe combined immunodeficiency hematopoietic progenitor cells in murine fetal thymic organ cultures.在干细胞因子、FLT-3配体、白细胞介素-7(IL-7)、IL-1和IL-15细胞因子存在的情况下,γc基因转移可恢复小鼠胎儿胸腺器官培养物中γc(-)X连锁重症联合免疫缺陷造血祖细胞的T细胞分化。
Blood. 1998 Dec 1;92(11):4090-7.
4
A novel myeloid-like NK cell progenitor in human umbilical cord blood.人脐带血中一种新型的髓样自然杀伤细胞祖细胞。
Blood. 2003 May 1;101(9):3444-50. doi: 10.1182/blood-2002-05-1501. Epub 2002 Dec 27.
5
NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions.从骨髓、脐带血和外周血干细胞分化而来的自然杀伤细胞表现出相似的表型和功能。
Eur J Immunol. 1998 Jun;28(6):1991-2002. doi: 10.1002/(SICI)1521-4141(199806)28:06<1991::AID-IMMU1991>3.0.CO;2-7.
6
Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15.在缺乏白细胞介素-15的情况下,小鼠胎儿和胚胎肝细胞可将人脐带血祖细胞分化为CD56阴性的自然杀伤细胞前体。
Exp Hematol. 2008 May;36(5):598-608. doi: 10.1016/j.exphem.2008.01.001. Epub 2008 Mar 4.
7
Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15.Flt3配体促进一种独特的CD34(+)人类自然杀伤细胞祖细胞的生成,该祖细胞对白细胞介素-15有反应。
Blood. 1998 Nov 15;92(10):3647-57.
8
Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors.白细胞介素-3、白细胞介素-7、白细胞介素15和粒细胞-巨噬细胞集落刺激因子对源自原始人类胎儿肝脏祖细胞的自然杀伤细胞和B细胞生成的不同作用。
Exp Hematol. 2000 Aug;28(8):961-73. doi: 10.1016/s0301-472x(00)00490-2.
9
Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo.常见细胞因子受体γ链依赖性细胞因子在体内自然杀伤细胞前体和外周自然杀伤细胞的产生、分化和成熟中的作用。
J Immunol. 2005 Feb 1;174(3):1213-21. doi: 10.4049/jimmunol.174.3.1213.
10
Ex vivo expansion of T, NK and CD34+ cells from umbilical cord blood.脐血中T细胞、NK细胞和CD34+细胞的体外扩增。
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Dec;13(6):1076-81.

引用本文的文献

1
Unravelling NK cell subset dynamics and specific gene signatures post-ibrutinib therapy in chronic lymphocytic leukaemia via single-cell transcriptomics.通过单细胞转录组学揭示慢性淋巴细胞白血病患者接受依鲁替尼治疗后自然杀伤细胞亚群动态及特定基因特征。
BMC Cancer. 2025 Apr 21;25(1):745. doi: 10.1186/s12885-025-14166-0.
2
Unlocking the regenerative key: Targeting stem cell factors for bone renewal.解锁再生密钥:靶向用于骨骼更新的干细胞因子。
J Tissue Eng. 2024 Oct 27;15:20417314241287491. doi: 10.1177/20417314241287491. eCollection 2024 Jan-Dec.
3
Nonclinical evaluations of deucravacitinib and Janus kinase inhibitors in homeostatic and inflammatory pathways.
在稳态和炎症通路中对德瓦鲁单抗和 Janus 激酶抑制剂的非临床评估。
Front Immunol. 2024 Sep 30;15:1437512. doi: 10.3389/fimmu.2024.1437512. eCollection 2024.
4
Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease.X 连锁严重联合免疫缺陷病患者基因治疗后的免疫重建。
Front Immunol. 2020 Nov 27;11:608653. doi: 10.3389/fimmu.2020.608653. eCollection 2020.
5
Natural Born Killers: NK Cells in Cancer Therapy.天生杀手:自然杀伤细胞在癌症治疗中的作用
Cancers (Basel). 2020 Jul 31;12(8):2131. doi: 10.3390/cancers12082131.
6
Novel Hemizygous IL2RG p.(Pro58Ser) Mutation Impairs IL-2 Receptor Complex Expression on Lymphocytes Causing X-Linked Combined Immunodeficiency.新型 IL2RG 半合子 p.(Pro58Ser) 突变导致 IL-2 受体复合物在淋巴细胞上表达缺陷,引起 X 连锁联合免疫缺陷。
J Clin Immunol. 2020 Apr;40(3):503-514. doi: 10.1007/s10875-020-00745-2. Epub 2020 Feb 19.
7
Gene therapy for severe combined immunodeficiencies and beyond.基因治疗重度联合免疫缺陷病及其他疾病。
J Exp Med. 2020 Jan 6;217(2). doi: 10.1084/jem.20190607.
8
JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians.JAK/STAT 信号通路在先天淋巴细胞调控中的作用:众神在前,守护者在后。
Immunol Rev. 2018 Nov;286(1):148-159. doi: 10.1111/imr.12705.
9
IL2rg Cytokines Enhance Umbilical Cord Blood CD34+ Cells Differentiation to T Cells.IL2rg细胞因子增强脐带血CD34+细胞向T细胞的分化。
Adv Pharm Bull. 2015 Dec;5(Suppl 1):615-9. doi: 10.15171/apb.2015.083. Epub 2015 Dec 31.
10
Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?X连锁重症联合免疫缺陷的基因治疗:我们目前的进展如何?
Hum Gene Ther. 2016 Feb;27(2):108-16. doi: 10.1089/hum.2015.137.